HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM | A202289 | MACLEODS PHARMACEUTICALS LTD
Highest NADAC/Unit
$0.0798
per ea
Lowest NADAC/Unit
$0.0621
per ea
Brand NDCs
0
Generic NDCs
9
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 33342005244LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB | $0.0798 | EA | Generic | — | 2026-06-17 |
| 33342005207LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB | $0.0798 | EA | Generic | — | 2026-06-17 |
| 33342005210LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB | $0.0798 | EA | Generic | — | 2026-06-17 |
| 33342005110LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB | $0.0755 | EA | Generic | — | 2026-06-17 |
| 33342005107LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB | $0.0755 | EA | Generic | — | 2026-06-17 |
| 33342005144LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB | $0.0755 | EA | Generic | — | 2026-06-17 |
Showing 6 of 9 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.